Alphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 27 2018 - 4:05PM
Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:
ATEC), a provider of innovative spine surgery solutions with a
mission to improve patient lives through the relentless pursuit of
superior outcomes, today announced that Terry Rich, President and
Chief Operating Officer, will present at the Rodman & Renshaw
20th Annual Global Investment Conference at 12:30 p.m. ET on
Thursday, September 6, 2018 in New York, NY.
A live webcast of the presentation will be
available online on the “Investor Relations” page of the Company’s
website at www.atecspine.com. A replay of the presentation will be
available on the same site for 90 days following the
webcast.
About Alphatec
Holdings, Inc.
Alphatec Holdings, Inc., through its
wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp
Surgical, Inc., is a medical device company that designs, develops,
and markets technology for the treatment of spinal disorders
associated with disease and degeneration, congenital deformities
and trauma. The Company's mission is to improve lives by providing
innovative spine surgery solutions through the relentless pursuit
of superior outcomes. The Company markets its products in the U.S.
via independent sales agents and a direct sales force.
Additional information can be found at
www.atecspine.com.
Forward-Looking Statements
Statements made in this press release and made
during the investor events referenced herein may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current
expectations and are subject to many risks and uncertainties that
could cause actual results to differ materially from those
described in the forward-looking statements.
These and other forward-looking statements are
not guarantees of future results and are subject to risks,
uncertainties, and assumptions that could cause actual results to
differ materially from those expressed in any forward-looking
statements. Forward-looking statements by their nature address
matters that are, to different degrees,
uncertain. Forward-looking statements include the references
to the Company’s strategy in significantly repositioning the
Alphatec brand and turning the Company into a growing
organization. The important factors that could cause actual
operating results to differ significantly from those expressed or
implied by such forward-looking statements include, but are not
limited to: the uncertainties regarding the Company’s ability to
recognize the expected synergies and other benefits of the SafeOp
acquisition;; the uncertainty of success in developing new products
or products currently in the Company’s pipeline; the uncertainties
in the Company’s ability to execute upon its strategic operating
plan; the uncertainties regarding the ability to successfully
license or acquire new products, and the commercial success of such
products; failure to achieve acceptance of the Company’s products
by the surgeon community, including Battalion and Arsenal
Deformity; failure to obtain FDA or other regulatory clearance or
approval for new products, or unexpected or prolonged delays in the
process; continuation of favorable fourth party reimbursement for
procedures performed using the Company’s products; unanticipated
expenses or liabilities or other adverse events affecting cash flow
or the Company’s ability to successfully control its costs or
achieve profitability; uncertainty of additional funding; the
Company’s ability to compete with other competing products and with
emerging new technologies; product liability exposure; an
unsuccessful outcome in any litigation in which the Company is a
defendant; patent infringement claims; claims related to the
Company’s intellectual property and the Company’s ability to meet
its financial obligations under its credit agreements and the
Orthotec settlement agreement. A further list and description of
these and other factors, risks and uncertainties can be found in
the Company’s most recent annual report, and any subsequent
quarterly and current reports, filed with the Securities and
Exchange Commission. Alphatec disclaims any intention or obligation
to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise unless
required by law.
Investor/Media Contact:
Tina Jacobsenir@atecspine.com(760) 494-6790
Company Contact:
Jeff BlackExecutive Vice President and Chief
Financial OfficerAlphatec Holdings, Inc.ir@atecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Sep 2023 to Sep 2024